Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases.
Ivanidze J, Sharbatdaran A, McCalla A, Brandmaier A, Andreopoulou E, Cristofanilli M, Cigler T, Balogun OD, Magge RS, Liechty B, Karakatsanis NA, Nehmeh SA, Agee MA, Jean J, Osborne JR, Beal K, Schwartz TH, Pannullo SC, Knisely JPS, Ramakrishna R. Ivanidze J, et al. Among authors: cristofanilli m. Eur J Radiol. 2024 Oct 15;181:111791. doi: 10.1016/j.ejrad.2024.111791. Online ahead of print. Eur J Radiol. 2024. PMID: 39423781 Review.
Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironment.
Stewart DC, Brisson BK, Dekky B, Berger AC, Yen W, Mauldin EA, Loebel C, Gillette D, Assenmacher CA, Quincey C, Stefanovski D, Cristofanilli M, Cukierman E, Burdick JA, Borges VF, Volk SW. Stewart DC, et al. Among authors: cristofanilli m. NPJ Breast Cancer. 2024 Oct 2;10(1):86. doi: 10.1038/s41523-024-00690-y. NPJ Breast Cancer. 2024. PMID: 39358397 Free PMC article.
Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors.
Reduzzi C, Nicolo' E, Singhal S, Venetis K, Ortega-Franco A, de Miguel-Perez D, Dipasquale A, Gouda MA, Saldanha EF, Kasi PM, Jantus-Lewintre E, Fusco N, Malapelle U, Gandara DR, Rolfo C, Serrano MJ, Cristofanilli M; International Society of Liquid Biopsy (ISLB). Reduzzi C, et al. Among authors: cristofanilli m. Crit Rev Oncol Hematol. 2024 Nov;203:104483. doi: 10.1016/j.critrevonc.2024.104483. Epub 2024 Aug 17. Crit Rev Oncol Hematol. 2024. PMID: 39159706 Review.
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials.
Nicolò E, Gandini S, Giugliano F, Uliano J, D'Ecclesiis O, Morganti S, Ferraro E, Trapani D, Tarantino P, Zagami P, Boldrini L, Caramella I, Carnevale Schianca A, Cristofanilli M, Locatelli MA, Esposito A, Belli C, Minchella I, Criscitiello C, Marra A, Curigliano G. Nicolò E, et al. Among authors: cristofanilli m. Eur J Cancer. 2024 Aug;207:114181. doi: 10.1016/j.ejca.2024.114181. Epub 2024 Jun 17. Eur J Cancer. 2024. PMID: 38909537
Preface.
Manai M, Boussen H, Cristofanilli M. Manai M, et al. Among authors: cristofanilli m. Int Rev Cell Mol Biol. 2024;384:xiii-xiv. doi: 10.1016/S1937-6448(24)00060-1. Int Rev Cell Mol Biol. 2024. PMID: 38637102 No abstract available.
Inflammatory breast cancer: Epidemiologic data and therapeutic results.
Boussen H, Berrazaga Y, Sherif Kullab, Manai M, Berrada N, Mejri N, Siala I, Levine PH, Cristofanilli M. Boussen H, et al. Among authors: cristofanilli m. Int Rev Cell Mol Biol. 2024;384:1-23. doi: 10.1016/bs.ircmb.2023.10.003. Epub 2024 Feb 6. Int Rev Cell Mol Biol. 2024. PMID: 38637094 Review.
461 results